121 related articles for article (PubMed ID: 4048162)
1. Comparative changes in rat liver cytosolic proteins by mirex, diethylnitrosamine, and dimethylnitrosamine exposure.
Timchalk C; Charles AK; Abraham R
Proc Soc Exp Biol Med; 1985 Nov; 180(2):214-8. PubMed ID: 4048162
[TBL] [Abstract][Full Text] [Related]
2. Nuclear ploidy of neonatal rat livers: effects of two hepatic carcinogens (mirex and dimethylnitrosamine).
Carlson J; Abraham R
J Toxicol Environ Health; 1985; 15(5):551-9. PubMed ID: 4046065
[TBL] [Abstract][Full Text] [Related]
3. The induction of chromosomal damage in rat hepatocytes and lymphocytes. I. Time-dependent changes of the clastogenic effects of diethylnitrosamine, dimethylnitrosamine and ethyl methanesulfonate.
Tates AD; Neuteboom I; de Vogel N; den Engelse L
Mutat Res; 1983 Jan; 107(1):131-51. PubMed ID: 6828034
[TBL] [Abstract][Full Text] [Related]
4. Comparative changes in hepatic DNA, RNA, protein, lipid, and glycogen induced by a subtoxic dose of CCl4 in chlordecone, mirex, and phenobarbital pretreated rats.
Bell AN; Mehendale HM
Toxicol Lett; 1987 Feb; 35(2-3):191-200. PubMed ID: 2435023
[TBL] [Abstract][Full Text] [Related]
5. In vivo repair of rat liver DNA damaged by dimethylnitrosamine or diethylnitrosamine.
Den Engelse L; Philippus EJ
Chem Biol Interact; 1977 Oct; 19(1):111-24. PubMed ID: 411580
[TBL] [Abstract][Full Text] [Related]
6. Molecular profiling of genes up-regulated during promotion by phenobarbital treatment in a medium-term rat liver bioassay.
Shibutani M; Takahashi N; Kobayashi T; Uneyama C; Masutomi N; Nishikawa A; Hirose M
Carcinogenesis; 2002 Jun; 23(6):1047-55. PubMed ID: 12082028
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic effects of mutagens/carcinogens after activation in a microsomal system in vitro I. Induction of chromosome aberrations and sister chromatid exchanges by diethylnitrosamine (DEN) and dimethylnitrosamine (DMN) in CHO cells in the presence of rat-liver microsomes.
Natarajan AT; Tates AD; Van Buul PP; Meijers M; De Vogel N
Mutat Res; 1976 Oct; 37(1):83-90. PubMed ID: 967188
[TBL] [Abstract][Full Text] [Related]
8. Reversible alteration in the expression of the gap junctional protein connexin 32 during tumor promotion in rat liver and its role during cell proliferation.
Neveu MJ; Hully JR; Paul DL; Pitot HC
Cancer Commun; 1990; 2(1):21-31. PubMed ID: 1973356
[TBL] [Abstract][Full Text] [Related]
9. Xenobiotics modulate the p53 response to DNA damage in preneoplastic enzyme-altered foci in rat liver; effects of diethylnitrosamine and phenobarbital.
Finnberg N; Stenius U; Högberg J
Toxicol Sci; 2000 Mar; 54(1):95-103. PubMed ID: 10746936
[TBL] [Abstract][Full Text] [Related]
10. Retinol (vitamin A) inhibition of dimethylnitrosamine (DMN) and diethylnitrosamine (DEN) induced sister-chromatid exchanges in V79 cells and mutations in Salmonella/microsome assays.
Huang CC
Mutat Res; 1987 Mar; 187(3):133-40. PubMed ID: 3547112
[TBL] [Abstract][Full Text] [Related]
11. Effect of copper administration on the incorporation of [3H]-thymidine into the liver DNA of rats stimulated by dimethylnitrosamine and diethylnitrosamine.
Sakai K; Murata N; Chiba K; Yamane Y
Carcinogenesis; 1981; 2(12):1261-6. PubMed ID: 7326825
[TBL] [Abstract][Full Text] [Related]
12. Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice.
Ward JM; Rice JM; Creasia D; Lynch P; Riggs C
Carcinogenesis; 1983 Aug; 4(8):1021-9. PubMed ID: 6872148
[TBL] [Abstract][Full Text] [Related]
13. Sodium phenobarbital-enhanced mutation frequency in the liver DNA of lacZ transgenic mice treated with diethylnitrosamine.
Okada N; Honda A; Kawabata M; Yajima N
Mutagenesis; 1997 May; 12(3):179-84. PubMed ID: 9175645
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the promoting effects of various agents in induction of preneoplastic lesions in rat liver.
Ito N; Tsuda H; Hasegawa R; Imaida K
Environ Health Perspect; 1983 Apr; 50():131-8. PubMed ID: 6191977
[TBL] [Abstract][Full Text] [Related]
15. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital.
Tamano S; Merlino GT; Ward JM
Carcinogenesis; 1994 Sep; 15(9):1791-8. PubMed ID: 7923571
[TBL] [Abstract][Full Text] [Related]
16. Expression Characteristics of Genes Hypermethylated and Downregulated in Rat Liver Specific to Nongenotoxic Hepatocarcinogens.
Ito Y; Nakajima K; Masubuchi Y; Kikuchi S; Saito F; Akahori Y; Jin M; Yoshida T; Shibutani M
Toxicol Sci; 2019 May; 169(1):122-136. PubMed ID: 30690589
[TBL] [Abstract][Full Text] [Related]
17. Anti-carcinogenic action of phenobarbital given simultaneously with diethylnitrosamine in the rat.
Barbason H; Mormont C; Massart S; Bouzahzah B
Eur J Cancer Clin Oncol; 1986 Sep; 22(9):1073-8. PubMed ID: 3780814
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent promoting activity of chloroform in rat liver foci bioassay.
Deml E; Oesterle D
Cancer Lett; 1985 Oct; 29(1):59-63. PubMed ID: 2866029
[TBL] [Abstract][Full Text] [Related]
19. Distinction between liver neoplasm promoting and syncarcinogenic effects demonstrated by exposure to phenobarbital or diethylnitrosamine either before or after N-2-fluorenylacetamide.
Williams GM; Furuya K
Carcinogenesis; 1984 Feb; 5(2):171-4. PubMed ID: 6697434
[TBL] [Abstract][Full Text] [Related]
20. Persistence and accumulation of (potential) single strand breaks in liver DNA of rats treated with diethylnitrosamine or dimethylnitrosamine: correlation with hepatocarcinogenicity.
Floot BG; Philippus EJ; Hart AA; Den Engelse L
Chem Biol Interact; 1979 May; 25(2-3):229-42. PubMed ID: 466734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
